SCHEMBL6392201

SCHEMBL6392201

Cc1ccc2c(n1)nc1c(C#N)c(C)c(-c3ccccc3)c(N3CC[C@H](N(C)C)C3)n12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.40
BTK Q06187 2/20 0.40
MRGPRX2 Q96LB1 2/20 0.40
MAPK10 P53779 1/20 0.40
ALDH1A1 P00352 3/20 0.36
HTR1D P28221 2/20 0.36
HTR3A P46098 2/20 0.36
HTR6 P50406 2/20 0.36
TMEM97 Q5BJF2 2/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR1B P28222 1/20 0.36
SLC6A3 Q01959 1/20 0.36
ADRA1B P35368 1/20 0.36
KDM4E B2RXH2 2/20 0.36
GLA P06280 2/20 0.36
GAA P10253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318849 0.90 CASP1 (0.38) MAPK8BTKMRGPRX2MAPK10ALDH1A1
Formic Acid SCHEMBL6310674 0.83 ALDH1A1 (0.46) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6311018 0.82 HSD17B10 (0.38) ALDH1A1HTR3ALMNAMEN1KMT2A
SCHEMBL5446972 0.81 MAPK8 (0.42) MAPK8BTKMRGPRX2MAPK10HTR1D
SCHEMBL6312402 0.81 ALDH1A1 (0.37) MAPK8BTKMRGPRX2MAPK10ALDH1A1
SCHEMBL6311058 0.81 HRH3 (0.36) MAPK8BTKMRGPRX2MAPK10ALDH1A1
SCHEMBL6311156 0.81 HSD17B10 (0.38) MAPK8BTKMRGPRX2MAPK10ALDH1A1
SCHEMBL6311811 0.81 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6310584 0.81 ALDH1A1 (0.47) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6674881 0.81 HTR3A (0.37) MAPK8BTKMRGPRX2MAPK10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 MAPK8 2579/4885BTK 2274/4885MRGPRX2 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.